5.60

4.11% -0.24

Verastem Inc (VSTM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$5.84

Aprire:

$5.88

Volume 24 ore:

2.04M

Relative Volume:

1.17

Capitalizzazione di mercato:

$421.79M

Reddito:

$30.91M

Utile/perdita netta:

$-209.47M

Rapporto P/E:

-1.6827

EPS:

-3.3279

Flusso di cassa netto:

$-147.13M

1 W Prestazione:

-12.23%

1M Prestazione:

-3.78%

6M Prestazione:

-42.39%

1 anno Prestazione:

-22.33%

Intervallo 1D:

$5.58

$6.00

Intervallo di 1 settimana:

$5.58

$6.79

Portata 52W:

$4.01

$11.24

Verastem Inc Stock (VSTM) Company Profile

Nome

Verastem Inc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

(781) 292-4200

Indirizzo

117 KENDRICK STREET, NEEDHAM, MA

Dipendente

Cinguettio

@VerastemOncolog

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

VSTM's Discussions on Twitter

Compare VSTM vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VSTM Verastem Inc	5.60	421.79M	30.91M	-209.47M	-147.13M	-3.3279
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Verastem Inc Stock (VSTM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-12	Ripresa	BTIG Research	Buy
2026-02-04	Iniziato	H.C. Wainwright	Buy
2025-10-16	Ripresa	Cantor Fitzgerald	Overweight
2025-04-10	Iniziato	Jefferies	Buy
2025-03-24	Reiterato	H.C. Wainwright	Buy
2024-12-31	Reiterato	BTIG Research	Buy
2024-09-30	Iniziato	Guggenheim	Buy
2023-11-21	Ripresa	BTIG Research	Buy
2023-09-27	Iniziato	B. Riley Securities	Buy
2023-06-15	Aggiornamento	Mizuho	Neutral → Buy
2022-09-07	Ripresa	Alliance Global Partners	Buy
2022-04-29	Ripresa	Cantor Fitzgerald	Overweight
2022-04-14	Iniziato	RBC Capital Mkts	Outperform
2022-03-09	Iniziato	Truist	Buy
2021-07-01	Iniziato	Alliance Global Partners	Buy
2021-05-24	Aggiornamento	BTIG Research	Neutral → Buy
2019-06-20	Downgrade	BTIG Research	Buy → Neutral
2019-05-10	Downgrade	Raymond James	Outperform → Mkt Perform
2018-07-13	Iniziato	BTIG Research	Buy
2018-05-02	Iniziato	Seaport Global Securities	Buy
2018-03-08	Iniziato	B. Riley FBR, Inc.	Buy
2017-09-07	Reiterato	H.C. Wainwright	Buy
2017-04-13	Iniziato	Oppenheimer	Outperform
2017-03-24	Reiterato	H.C. Wainwright	Buy
2015-09-29	Downgrade	Cantor Fitzgerald	Buy → Hold
2015-09-29	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2015-09-29	Downgrade	Jefferies	Buy → Hold
2015-09-29	Downgrade	Raymond James	Strong Buy → Outperform
2015-09-28	Downgrade	Mizuho	Buy → Neutral
2015-09-28	Downgrade	ROTH Capital	Buy → Neutral
2015-09-09	Iniziato	Raymond James	Strong Buy
2015-05-12	Reiterato	UBS	Buy
2015-04-08	Iniziato	H.C. Wainwright	Buy
2015-01-23	Reiterato	ROTH Capital	Buy
2014-07-08	Ripresa	Oppenheimer	Perform
2014-02-11	Iniziato	Mizuho	Buy

Mostra tutto

Verastem Inc Borsa (VSTM) Ultime notizie

Mar 14, 2026

Verastem stock initiated at Buy by BTIG with $19 price target - Investing.com Nigeria

Mar 11, 2026

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High? - Yahoo Finance

Mar 11, 2026

Mar 10, 2026

Jefferies Financial Group Inc. Increases Stake in Verastem, Inc. $VSTM - MarketBeat

Mar 10, 2026

Mar 09, 2026

Earnings call transcript: Verastem’s Q4 2025 results highlight oncology growth - Investing.com Nigeria

Mar 09, 2026

Verastem Earnings Call: Early Momentum, Long Runway Risks - TipRanks

Mar 09, 2026

Mar 07, 2026

Verastem (NASDAQ:VSTM) Raised to Hold at Wall Street Zen - MarketBeat

Mar 07, 2026

Mar 06, 2026

Verastem (VSTM) reports Q4 loss, beats revenue estimates - MSN

Mar 06, 2026

Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026

Jefferies Maintains Buy on Verastem, Inc. (VSTM) March 2026 - Meyka

Mar 06, 2026

Mar 05, 2026

Verastem (VSTM) Q4 Revenue Debut Highlights Ongoing Losses And Tests Bullish Profitability Timeline - simplywall.st

Mar 05, 2026

Verastem 2025 Financial Results: Q4 and Annual Revenue & LossNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 05, 2026

Why Did Verastem Stock Jump After-Hours Despite An Earnings Miss? - Stocktwits

Mar 05, 2026

Jefferies reiterates Verastem stock rating on launch progress By Investing.com - Investing.com Canada

Mar 05, 2026

Verastem, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 05, 2026

Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 05, 2026